For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Checkpoint Therapeutics Inc’s stock clocked out at $3.17, down -0.94% from its previous closing price of $3.20. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 0.87 million shares were traded. CKPT stock price reached its highest trading level at $3.35 during the session, while it also had its lowest trading level at $3.13.
Ratios:
To gain a deeper understanding of CKPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.B. Riley Securities initiated its Buy rating on June 09, 2021, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 18 ’24 when Oliviero James F III sold 602,167 shares for $3.87 per share. The transaction valued at 2,330,386 led to the insider holds 3,414,813 shares of the business.
Oliviero James F III sold 220,230 shares of CKPT for $744,377 on Dec 19 ’24. The CEO, President and Director now owns 3,194,583 shares after completing the transaction at $3.38 per share. On Dec 18 ’24, another insider, GRAY WILLIAM GARRETT, who serves as the Chief Financial Officer of the company, sold 268,432 shares for $4.01 each. As a result, the insider received 1,076,412 and left with 1,032,754 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 154799024 and an Enterprise Value of 150360544. For the stock, the TTM Price-to-Sale (P/S) ratio is 3095.90. Its current Enterprise Value per Revenue stands at 1927.699.
Stock Price History:
The Beta on a monthly basis for CKPT is 1.37, which has changed by 0.72043014 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -12.42%, while the 200-Day Moving Average is calculated to be 25.40%.
Shares Statistics:
It appears that CKPT traded 1.47M shares on average per day over the past three months and 1001200 shares per day over the past ten days. A total of 45.10M shares are outstanding, with a floating share count of 37.85M. Insiders hold about 22.49% of the company’s shares, while institutions hold 15.76% stake in the company. Shares short for CKPT as of 1730332800 were 5563543 with a Short Ratio of 5.42, compared to 1727654400 on 4375843. Therefore, it implies a Short% of Shares Outstanding of 5563543 and a Short% of Float of 13.370000000000001.
